Astec LifeSciences dividend yield

Per cent unless marked ×
Tap a line for its trendCurrentlast 12MFY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
—−15.94×8.70×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−6.1%——
−6.7%——
—−15.94×8.70×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,295 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPontAnnuals · FY-end closes
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Dividend Coverage (PAT/Dividends Paid)8.70-15.94———
Earnings Yield %————-6.15
FCF Yield %————-6.66
Dividend Coverage (NI/Dvd)8.70-15.94———
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.